Skip to main content
Tech.euFundingExplorerBeta

Tubulis Technologies

Tubulis Technologies generates uniquely matched protein-drug conjugates.

Munich, GermanyFounded 2019tubulis.com ↗
Healthtech
← All companies
Total raised
€379M
€378,700,000
Funding rounds
3
Investors
18
distinct backers
Active since
2020-07
latest 2025-10

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood62
base rate 50% for Series C
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood24
base rate 12% (2+ rounds)
  • ▲ 3 rounds raised
  • ▲ €100M+ raised
  • ▲ 7y since founding

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2025-10-15Series C€308MAndera Partners,Ascenta Capital,Bayern Kapital,Deep Track Capital,EQT Life Sciences,Existing investors+8 moreView deal →
2022-05-03Series B€60MAndera Partners,Bayern Kapital,BioMedPartners,Coparion,Evotec,FundPlus+3 moreView deal →
2020-07-21Series A€11MBioMedPartners,High-Tech GrunderfondsView deal →

Investors

18
Andera PartnersAscenta CapitalBayern KapitalBioMedPartnersCoparionDeep Track CapitalEQT Life SciencesEvotecExisting investorsFrazier Life SciencesFundPlusHigh-Tech GrunderfondsHigh-Tech Gründerfonds (HTGF)Nextech InvestOCCIDENTSeventure PartnersVenrock Healthcare Capital PartnersWellington Management

Related news

Similar companies

same sector or country